CoreAge Rx vs Nova

The verdict for women

CoreAge Rx edges out Nova on the Metabolic-Fit Score, 86 to 37 (B vs C). Someone considering both compounded injection options who wants an advertised flat price without a required subscription and will confirm the exact prescription, state access and refund terms.

Nova is still a genuine option — start with what will otherwise confuse you: this is not Nova MD. Different operator, different owners, and Nova MD is the one carrying an FDA warning letter naming its own domain — this company carries none. What Nova sells is a required $99 monthly membership plus medication, quoted all-in on the product pages at $169 a month for a daily semaglutide oral dose, $174 for the daily tirzepatide oral dose, $198 for the weekly semaglutide injection and $210 for the weekly tirzepatide injection. Offering a daily oral route alongside the weekly shot is genuinely useful, and coverage has just widened to forty-nine states with California still to come. Then the pricing stops agreeing with itself. The semaglutide page leads with $198 above an FAQ headed "What does the $229/mo include?", and the tirzepatide page repeats the trick, leading with $210 above an FAQ headed "$279/mo". Two further products, the needle-free weekly tablets, are advertised in the navigation while both of their pages load almost empty and carry no price at all. And the pricing page promises you are charged only if a provider prescribes, while the refund policy says the consultation and membership fees are not refundable even when the provider declines you. Weigh the six women's-health factors below against your own priorities.